July 13, 2017 / 11:45 AM / 2 months ago

BRIEF-Immune Pharma announces filing of patent protecting use of ceplene

July 13 (Reuters) - Immune Pharmaceuticals Inc:

* Immune Pharmaceuticals announces filing of a patent protecting use of ceplene (histamine dihydrochloride) in hematologic cancers

* Immune Pharmaceuticals Inc - ‍patent aims to protect use of ceplene in forms of cancer where malignant cells may harbor a mutated oncogene, NPM1​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below